Literature DB >> 32277781

Genetically Elevated LDL Associates with Lower Risk of Intracerebral Hemorrhage.

Guido J Falcone1, Elayna Kirsch1, Julian N Acosta1, Rommell B Noche1, Audrey Leasure1, Sandro Marini2, Jaeyoon Chung2, Magdy Selim3, James F Meschia4, Devin L Brown5, Bradford B Worrall6, David L Tirschwell7, Jeremiasz M Jagiella8, Helena Schmidt9, Jordi Jimenez-Conde10,11, Israel Fernandez-Cadenas12, Arne Lindgren13,14, Agnieszka Slowik8, Dipender Gill15, Michael Holmes16,17, Chia-Ling Phuah18, Nils H Petersen1, Charles N Matouk Md19, Murat Gunel19, Lauren Sansing20, Derrick Bennett17, Zhengming Chen17, Luan L Sun21, Robert Clarke1, Robin G Walters16,17, Thomas M Gill22, Alessandro Biffi2,23,24,25, Sekar Kathiresan2,23,26, Carl D Langefeld27, Daniel Woo28, Jonathan Rosand2,23,29,30, Kevin N Sheth1, Christopher D Anderson2,23,29,30.   

Abstract

OBJECTIVE: Observational studies point to an inverse correlation between low-density lipoprotein (LDL) cholesterol levels and risk of intracerebral hemorrhage (ICH), but it remains unclear whether this association is causal. We tested the hypothesis that genetically elevated LDL is associated with reduced risk of ICH.
METHODS: We constructed one polygenic risk score (PRS) per lipid trait (total cholesterol, LDL, high-density lipoprotein [HDL], and triglycerides) using independent genomewide significant single nucleotide polymorphisms (SNPs) for each trait. We used data from 316,428 individuals enrolled in the UK Biobank to estimate the effect of each PRS on its corresponding trait, and data from 1,286 ICH cases and 1,261 matched controls to estimate the effect of each PRS on ICH risk. We used these estimates to conduct Mendelian Randomization (MR) analyses.
RESULTS: We identified 410, 339, 393, and 317 lipid-related SNPs for total cholesterol, LDL, HDL, and triglycerides, respectively. All four PRSs were strongly associated with their corresponding trait (all p < 1.00 × 10-100 ). While one SD increase in the PRSs for total cholesterol (odds ratio [OR] = 0.92; 95% confidence interval [CI] = 0.85-0.99; p = 0.03) and LDL cholesterol (OR = 0.88; 95% CI = 0.81-0.95; p = 0.002) were inversely associated with ICH risk, no significant associations were found for HDL and triglycerides (both p > 0.05). MR analyses indicated that 1mmol/L (38.67mg/dL) increase of genetically instrumented total and LDL cholesterol were associated with 23% (OR = 0.77; 95% CI = 0.65-0.98; p = 0.03) and 41% lower risks of ICH (OR = 0.59; 95% CI = 0.42-0.82; p = 0.002), respectively.
INTERPRETATION: Genetically elevated LDL levels were associated with lower risk of ICH, providing support for a potential causal role of LDL cholesterol in ICH. ANN NEUROL 2020 ANN NEUROL 2020;88:56-66.
© 2020 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32277781      PMCID: PMC7523882          DOI: 10.1002/ana.25740

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   11.274


  36 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

2.  Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage.

Authors:  Daniel Woo; Guido J Falcone; William J Devan; W Mark Brown; Alessandro Biffi; Timothy D Howard; Christopher D Anderson; H Bart Brouwers; Valerie Valant; Thomas W K Battey; Farid Radmanesh; Miriam R Raffeld; Sylvia Baedorf-Kassis; Ranjan Deka; Jessica G Woo; Lisa J Martin; Mary Haverbusch; Charles J Moomaw; Guangyun Sun; Joseph P Broderick; Matthew L Flaherty; Sharyl R Martini; Dawn O Kleindorfer; Brett Kissela; Mary E Comeau; Jeremiasz M Jagiella; Helena Schmidt; Paul Freudenberger; Alexander Pichler; Christian Enzinger; Björn M Hansen; Bo Norrving; Jordi Jimenez-Conde; Eva Giralt-Steinhauer; Roberto Elosua; Elisa Cuadrado-Godia; Carolina Soriano; Jaume Roquer; Peter Kraft; Alison M Ayres; Kristin Schwab; Jacob L McCauley; Joanna Pera; Andrzej Urbanik; Natalia S Rost; Joshua N Goldstein; Anand Viswanathan; Eva-Maria Stögerer; David L Tirschwell; Magdy Selim; Devin L Brown; Scott L Silliman; Bradford B Worrall; James F Meschia; Chelsea S Kidwell; Joan Montaner; Israel Fernandez-Cadenas; Pilar Delgado; Rainer Malik; Martin Dichgans; Steven M Greenberg; Peter M Rothwell; Arne Lindgren; Agnieszka Slowik; Reinhold Schmidt; Carl D Langefeld; Jonathan Rosand
Journal:  Am J Hum Genet       Date:  2014-03-20       Impact factor: 11.025

3.  UK Biobank shares the promise of big data.

Authors:  Nancy Cox
Journal:  Nature       Date:  2018-10       Impact factor: 49.962

Review 4.  An introduction to Mendelian randomization with applications in neurology.

Authors:  Phillip H Allman; Inmaculada B Aban; Hemant K Tiwari; Gary R Cutter
Journal:  Mult Scler Relat Disord       Date:  2018-06-20       Impact factor: 4.339

5.  A map of human genome variation from population-scale sequencing.

Authors:  Gonçalo R Abecasis; David Altshuler; Adam Auton; Lisa D Brooks; Richard M Durbin; Richard A Gibbs; Matt E Hurles; Gil A McVean
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

6.  Exploiting common genetic variation to make anticoagulation safer.

Authors: 
Journal:  Stroke       Date:  2009-01-15       Impact factor: 7.914

Review 7.  Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials.

Authors:  James S McKinney; William J Kostis
Journal:  Stroke       Date:  2012-05-15       Impact factor: 7.914

8.  Fast and accurate genotype imputation in genome-wide association studies through pre-phasing.

Authors:  Bryan Howie; Christian Fuchsberger; Matthew Stephens; Jonathan Marchini; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2012-07-22       Impact factor: 38.330

9.  Prospects for using risk scores in polygenic medicine.

Authors:  Cathryn M Lewis; Evangelos Vassos
Journal:  Genome Med       Date:  2017-11-13       Impact factor: 11.117

10.  Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.

Authors:  Derek Klarin; Scott M Damrauer; Kelly Cho; Yan V Sun; Tanya M Teslovich; Jacqueline Honerlaw; David R Gagnon; Scott L DuVall; Jin Li; Gina M Peloso; Mark Chaffin; Aeron M Small; Jie Huang; Hua Tang; Julie A Lynch; Yuk-Lam Ho; Dajiang J Liu; Connor A Emdin; Alexander H Li; Jennifer E Huffman; Jennifer S Lee; Pradeep Natarajan; Rajiv Chowdhury; Danish Saleheen; Marijana Vujkovic; Aris Baras; Saiju Pyarajan; Emanuele Di Angelantonio; Benjamin M Neale; Aliya Naheed; Amit V Khera; John Danesh; Kyong-Mi Chang; Gonçalo Abecasis; Cristen Willer; Frederick E Dewey; David J Carey; John Concato; J Michael Gaziano; Christopher J O'Donnell; Philip S Tsao; Sekar Kathiresan; Daniel J Rader; Peter W F Wilson; Themistocles L Assimes
Journal:  Nat Genet       Date:  2018-10-01       Impact factor: 38.330

View more
  8 in total

Review 1.  Genetics of common cerebral small vessel disease.

Authors:  Constance Bordes; Muralidharan Sargurupremraj; Aniket Mishra; Stéphanie Debette
Journal:  Nat Rev Neurol       Date:  2022-01-05       Impact factor: 42.937

Review 2.  Stroke Prevention After Intracerebral Hemorrhage: Where Are We Now?

Authors:  Hae Young Baang; Kevin N Sheth
Journal:  Curr Cardiol Rep       Date:  2021-10-01       Impact factor: 2.931

Review 3.  Plant-based diets and long-term health: findings from the EPIC-Oxford study.

Authors:  Timothy J Key; Keren Papier; Tammy Y N Tong
Journal:  Proc Nutr Soc       Date:  2021-10-27       Impact factor: 6.391

Review 4.  Use of Lipid-Lowering Drugs After Intracerebral Hemorrhage.

Authors:  Ashkan Shoamanesh; Magdy Selim
Journal:  Stroke       Date:  2022-06-06       Impact factor: 10.170

Review 5.  Genetics and Epigenetics of Spontaneous Intracerebral Hemorrhage.

Authors:  Eva Giralt-Steinhauer; Joan Jiménez-Balado; Isabel Fernández-Pérez; Lucía Rey Álvarez; Ana Rodríguez-Campello; Ángel Ois; Elisa Cuadrado-Godia; Jordi Jiménez-Conde; Jaume Roquer
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

6.  Ethnic and Racial Variation in Intracerebral Hemorrhage Risk Factors and Risk Factor Burden.

Authors:  Steven J Kittner; Padmini Sekar; Mary E Comeau; Christopher D Anderson; Gunjan Y Parikh; Tachira Tavarez; Matthew L Flaherty; Fernando D Testai; Michael R Frankel; Michael L James; Gene Sung; Mitchell S V Elkind; Bradford B Worrall; Chelsea S Kidwell; Nicole R Gonzales; Sebastian Koch; Christiana E Hall; Lee Birnbaum; Douglas Mayson; Bruce Coull; Marc D Malkoff; Kevin N Sheth; Jacob L McCauley; Jennifer Osborne; Misty Morgan; Lee A Gilkerson; Tyler P Behymer; Stacie L Demel; Charles J Moomaw; Jonathan Rosand; Carl D Langefeld; Daniel Woo
Journal:  JAMA Netw Open       Date:  2021-08-02

Review 7.  The Association between Low Levels of Low Density Lipoprotein Cholesterol and Intracerebral Hemorrhage: Cause for Concern?

Authors:  Chen Gurevitz; Eitan Auriel; Avishay Elis; Ran Kornowski
Journal:  J Clin Med       Date:  2022-01-21       Impact factor: 4.241

8.  Milk and Fermented Milk Consumption and Risk of Stroke: Longitudinal Study.

Authors:  Erika Olsson; Susanna C Larsson; Jonas Höijer; Lena Kilander; Liisa Byberg
Journal:  Nutrients       Date:  2022-03-03       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.